ID   PGES2_HUMAN             Reviewed;         377 AA.
AC   Q9H7Z7; Q53EW9; Q5SYV6; Q96GI0; Q96GL2;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Prostaglandin E synthase 2;
DE   AltName: Full=Membrane-associated prostaglandin E synthase-2 {ECO:0000303|PubMed:12804604};
DE            Short=mPGE synthase-2 {ECO:0000303|PubMed:12804604};
DE   AltName: Full=Microsomal prostaglandin E synthase 2;
DE            Short=mPGES-2;
DE   AltName: Full=Prostaglandin-H(2) E-isomerase;
DE            EC=5.3.99.3 {ECO:0000269|PubMed:12804604, ECO:0000269|PubMed:18198127};
DE   Contains:
DE     RecName: Full=Prostaglandin E synthase 2 truncated form;
GN   Name=PTGES2; Synonyms=C9orf15, PGES2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=11866447; DOI=10.1006/bbrc.2002.6531;
RA   Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K.,
RA   Kojima M., Ito S., Watanabe K.;
RT   "Identification and characterization of a novel type of membrane-
RT   associated prostaglandin E synthase.";
RL   Biochem. Biophys. Res. Commun. 291:884-889(2002).
RN   [6]
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-110 AND CYS-113, AND ENZYME
RP   REGULATION.
RX   PubMed=12804604; DOI=10.1016/S0006-291X(03)01025-8;
RA   Watanabe K., Ohkubo H., Niwa H., Tanikawa N., Koda N., Ito S.,
RA   Ohmiya Y.;
RT   "Essential 110Cys in active site of membrane-associated prostaglandin
RT   E synthase-2.";
RL   Biochem. Biophys. Res. Commun. 306:577-581(2003).
RN   [7]
RP   CLEAVAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=12835322; DOI=10.1074/jbc.M305108200;
RA   Murakami M., Nakashima K., Kamei D., Masuda S., Ishikawa Y., Ishii T.,
RA   Ohmiya Y., Watanabe K., Kudo I.;
RT   "Cellular prostaglandin E2 production by membrane-bound prostaglandin
RT   E synthase-2 via both cyclooxygenases-1 and -2.";
RL   J. Biol. Chem. 278:37937-37947(2003).
RN   [8]
RP   INTERACTION WITH EXOSC10.
RX   PubMed=15231747; DOI=10.1101/gr.2122004;
RA   Lehner B., Sanderson C.M.;
RT   "A protein interaction framework for human mRNA degradation.";
RL   Genome Res. 14:1315-1323(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND CAUTION.
RX   PubMed=18198127; DOI=10.1016/j.bbrc.2008.01.029;
RA   Watanabe K., Ito S., Yamamoto S.;
RT   "Studies on membrane-associated prostaglandin E synthase-2 with
RT   reference to production of 12L-hydroxy-5,8,10-heptadecatrienoic acid
RT   (HHT).";
RL   Biochem. Biophys. Res. Commun. 367:782-786(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Isomerase that catalyzes the conversion of PGH2 into the
CC       more stable prostaglandin E2 (PGE2). {ECO:0000269|PubMed:12804604,
CC       ECO:0000269|PubMed:18198127}.
CC   -!- CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-
CC       hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-11-alpha,15-
CC       dihydroxy-9-oxoprosta-5,13-dienoate. {ECO:0000269|PubMed:12804604,
CC       ECO:0000269|PubMed:18198127}.
CC   -!- ENZYME REGULATION: Isomerase activity is increased by sulfhydril
CC       compounds. Dithiothreitol (DTT) is most effective, followed by
CC       dihydrolipoic acid, glutathione (GSH) and 2-mercaptoethanol.
CC       {ECO:0000269|PubMed:12804604}.
CC   -!- PATHWAY: Lipid metabolism; prostaglandin biosynthesis.
CC   -!- SUBUNIT: Homodimer. May interact with CEBPB (By similarity).
CC       Interacts with EXOSC10. {ECO:0000250|UniProtKB:Q66LN0,
CC       ECO:0000250|UniProtKB:Q8BWM0, ECO:0000269|PubMed:15231747}.
CC   -!- INTERACTION:
CC       Q5VU69:C1orf189; NbExp=3; IntAct=EBI-681645, EBI-10247920;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:12835322}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: Prostaglandin E synthase 2 truncated form:
CC       Cytoplasm, perinuclear region {ECO:0000269|PubMed:12835322}.
CC       Note=Synthesized as a Golgi membrane-bound protein, which is
CC       further cleaved into the predominant soluble truncated form. The
CC       truncated form is cytoplasmic and is enriched in the perinuclear
CC       region. {ECO:0000269|PubMed:12835322}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in the heart,
CC       including apex, inter-ventricular septum, both atria and
CC       ventricles, but not in the aorta. Also expressed in fetal heart.
CC       Detected in various regions of the brain: cerebellum; occipital,
CC       frontal and parietal lobes. Also expressed in the lymph nodes,
CC       skeletal muscle, kidney and trachea, but not in the thymus or
CC       lung. Overexpressed in colorectal cancer.
CC       {ECO:0000269|PubMed:11866447}.
CC   -!- SIMILARITY: Belongs to the GST superfamily. {ECO:0000305}.
CC   -!- CAUTION: Heme and GST are not required for prostaglandin synthase
CC       activity, but the protein copurifies with heme and GST when DTT is
CC       omitted during the purification procedure. The GSH-heme complex-
CC       bound enzyme (mPGES-2h) has been proposed to act as a lyase and
CC       catalyze the degradation of prostaglandin E2 H2 (PGH2) to 12(S)-
CC       hydroxy-5(Z),8(E),10(E)-heptadecatrienoic acid (HHT) and
CC       malondialdehyde (MDA), but this activity may well be spurious.
CC       According to PubMed:18198127, boiling the enzyme leads to loss of
CC       prostaglandin synthase activity, but does not eliminate the lyase
CC       activity. Besides, free heme can catalyze the formation of 12L-
CC       hydroxy-5,8,10-heptadecatrienoic acid (HHT).
CC       {ECO:0000269|PubMed:18198127, ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI13822.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK024100; BAB14826.1; -; mRNA.
DR   EMBL; AK223520; BAD97240.1; -; mRNA.
DR   EMBL; AL590708; CAI13821.1; -; Genomic_DNA.
DR   EMBL; AL590708; CAI13822.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC009397; AAH09397.2; -; mRNA.
DR   EMBL; BC009456; AAH09456.1; -; mRNA.
DR   EMBL; BC011613; AAH11613.1; -; mRNA.
DR   CCDS; CCDS6891.1; -.
DR   RefSeq; NP_001243264.1; NM_001256335.1.
DR   RefSeq; NP_079348.1; NM_025072.6.
DR   RefSeq; NP_945176.1; NM_198938.2.
DR   UniGene; Hs.495219; -.
DR   ProteinModelPortal; Q9H7Z7; -.
DR   SMR; Q9H7Z7; -.
DR   BioGrid; 123135; 21.
DR   IntAct; Q9H7Z7; 7.
DR   STRING; 9606.ENSP00000345341; -.
DR   BindingDB; Q9H7Z7; -.
DR   ChEMBL; CHEMBL4411; -.
DR   GuidetoPHARMACOLOGY; 1378; -.
DR   SwissLipids; SLP:000001095; -.
DR   iPTMnet; Q9H7Z7; -.
DR   PhosphoSitePlus; Q9H7Z7; -.
DR   BioMuta; PTGES2; -.
DR   DMDM; 73921741; -.
DR   EPD; Q9H7Z7; -.
DR   MaxQB; Q9H7Z7; -.
DR   PaxDb; Q9H7Z7; -.
DR   PeptideAtlas; Q9H7Z7; -.
DR   PRIDE; Q9H7Z7; -.
DR   TopDownProteomics; Q9H7Z7; -.
DR   DNASU; 80142; -.
DR   Ensembl; ENST00000338961; ENSP00000345341; ENSG00000148334.
DR   GeneID; 80142; -.
DR   KEGG; hsa:80142; -.
DR   UCSC; uc004bti.4; human.
DR   CTD; 80142; -.
DR   DisGeNET; 80142; -.
DR   GeneCards; PTGES2; -.
DR   HGNC; HGNC:17822; PTGES2.
DR   HPA; HPA020631; -.
DR   HPA; HPA020733; -.
DR   MIM; 608152; gene.
DR   neXtProt; NX_Q9H7Z7; -.
DR   OpenTargets; ENSG00000148334; -.
DR   PharmGKB; PA33949; -.
DR   eggNOG; KOG3029; Eukaryota.
DR   eggNOG; ENOG410XS2X; LUCA.
DR   GeneTree; ENSGT00390000000224; -.
DR   HOGENOM; HOG000231901; -.
DR   HOVERGEN; HBG069136; -.
DR   InParanoid; Q9H7Z7; -.
DR   KO; K05309; -.
DR   OMA; WFYDVKA; -.
DR   OrthoDB; EOG091G0AEH; -.
DR   PhylomeDB; Q9H7Z7; -.
DR   TreeFam; TF314304; -.
DR   BioCyc; MetaCyc:HS07514-MONOMER; -.
DR   BRENDA; 5.3.99.3; 2681.
DR   Reactome; R-HSA-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   UniPathway; UPA00662; -.
DR   ChiTaRS; PTGES2; human.
DR   GeneWiki; PTGES2; -.
DR   GenomeRNAi; 80142; -.
DR   PRO; PR:Q9H7Z7; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000148334; -.
DR   CleanEx; HS_PTGES2; -.
DR   ExpressionAtlas; Q9H7Z7; baseline and differential.
DR   Genevisible; Q9H7Z7; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:Ensembl.
DR   GO; GO:0009055; F:electron carrier activity; IEA:InterPro.
DR   GO; GO:0043295; F:glutathione binding; ISS:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0016829; F:lyase activity; ISS:UniProtKB.
DR   GO; GO:0050220; F:prostaglandin-E synthase activity; TAS:Reactome.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0019371; P:cyclooxygenase pathway; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   CDD; cd03197; GST_C_mPGES2; 1.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR034334; PGES2.
DR   InterPro; IPR034335; PGES2_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   Pfam; PF13417; GST_N_3; 1.
DR   SFLD; SFLDG01203; Prostaglandin_E_synthase_like; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS00195; GLUTAREDOXIN_1; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Golgi apparatus; Isomerase; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Phosphoprotein; Polymorphism;
KW   Prostaglandin biosynthesis; Prostaglandin metabolism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    377       Prostaglandin E synthase 2.
FT                                /FTId=PRO_0000013127.
FT   CHAIN        88    377       Prostaglandin E synthase 2 truncated
FT                                form. {ECO:0000250}.
FT                                /FTId=PRO_0000013128.
FT   TOPO_DOM      1     57       Lumenal. {ECO:0000255}.
FT   TRANSMEM     58     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75    377       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       90    193       Glutaredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00686}.
FT   DOMAIN      263    377       GST C-terminal.
FT   REGION      164    165       Glutathione binding. {ECO:0000250}.
FT   BINDING     148    148       Glutathione; via amide nitrogen and
FT                                carbonyl oxygen. {ECO:0000250}.
FT   SITE         87     88       Cleavage. {ECO:0000250}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     298    298       R -> H (in dbSNP:rs13283456).
FT                                /FTId=VAR_049494.
FT   MUTAGEN     110    110       C->S: Loss of function.
FT                                {ECO:0000269|PubMed:12804604}.
FT   MUTAGEN     113    113       C->S: Slightly decreased enzyme activity.
FT                                {ECO:0000269|PubMed:12804604}.
FT   CONFLICT    319    319       G -> S (in Ref. 2; BAD97240).
FT                                {ECO:0000305}.
SQ   SEQUENCE   377 AA;  41943 MW;  82F2DF867BB8337C CRC64;
     MDPAARVVRA LWPGGCALAW RLGGRPQPLL PTQSRAGFAG AAGGPSPVAA ARKGSPRLLG
     AAALALGGAL GLYHTARWHL RAQDLHAERS AAQLSLSSRL QLTLYQYKTC PFCSKVRAFL
     DFHALPYQVV EVNPVRRAEI KFSSYRKVPI LVAQEGESSQ QLNDSSVIIS ALKTYLVSGQ
     PLEEIITYYP AMKAVNEQGK EVTEFGNKYW LMLNEKEAQQ VYGGKEARTE EMKWRQWADD
     WLVHLISPNV YRTPTEALAS FDYIVREGKF GAVEGAVAKY MGAAAMYLIS KRLKSRHRLQ
     DNVREDLYEA ADKWVAAVGK DRPFMGGQKP NLADLAVYGV LRVMEGLDAF DDLMQHTHIQ
     PWYLRVERAI TEASPAH
//
